ScoreWhy is Biocon Ltd. ?
1
Positive results in Mar 26
- PAT(Latest six months) Higher at Rs 627.61 cr
- PBT LESS OI(Q) At Rs 275.40 cr has Grown at 70.7% (vs previous 4Q average)
- DEBT-EQUITY RATIO(HY) Lowest at 0.45 times
2
Stock is technically in a Bullish range
- The technical trend has improved from Mildly Bullish on 20-May-26
- Multiple factors for the stock are Bullish like MACD, Bollinger Band, KST and OBV
3
With ROCE of 3.2, it has a Attractive valuation with a 1.8 Enterprise value to Capital Employed
- The stock is trading at a discount compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 30.21%, its profits have fallen by -21.1%
4
Rising Promoter Confidence
- Promoters have increased their stake in the company by 14.5% over the previous quarter and currently hold 44.91% of the company
- Promoters increasing their stake is a sign of high confidence in the future of the business
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Biocon should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Biocon for you?
Medium Risk, High Return
Absolute
Risk Adjusted
Volatility
Biocon
25.24%
1.15
26.32%
Sensex
-1.65%
-0.64
13.06%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
19.16%
EBIT Growth (5y)
11.24%
EBIT to Interest (avg)
4.69
Debt to EBITDA (avg)
4.70
Net Debt to Equity (avg)
0.34
Sales to Capital Employed (avg)
0.43
Tax Ratio
13.00%
Dividend Payout Ratio
5.92%
Pledged Shares
0
Institutional Holding
31.53%
ROCE (avg)
5.99%
ROE (avg)
4.95%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
80
Industry P/E
37
Price to Book Value
2.06
EV to EBIT
54.88
EV to EBITDA
23.08
EV to Capital Employed
1.79
EV to Sales
4.71
PEG Ratio
0.83
Dividend Yield
0.12%
ROCE (Latest)
3.29%
ROE (Latest)
2.26%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend7What is working for the Company
PAT(9M)
Higher at Rs 782.21 Cr
DEBT-EQUITY RATIO(HY)
Lowest at 0.45 times
-9What is not working for the Company
PBT LESS OI(Q)
At Rs 86.60 cr has Fallen at -31.9% (vs previous 4Q average
ROCE(HY)
Lowest at 3.72%
PAT(Q)
At Rs 154.60 cr has Fallen at -19.5% (vs previous 4Q average
NON-OPERATING INCOME(Q)
is 38.63 % of Profit Before Tax (PBT
Loading Valuation Snapshot...
Here's what is working for Biocon
Debt-Equity Ratio - Half Yearly
Lowest at 0.45 times
in the last five half yearly periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Here's what is not working for Biocon
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 86.60 cr has Fallen at -31.9% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs 127.08 CrMOJO Watch
Near term PBT trend is very negative
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
At Rs 154.60 cr has Fallen at -19.5% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 192.14 CrMOJO Watch
Near term PAT trend is very negative
PAT (Rs Cr)
Non Operating Income - Quarterly
is 38.63 % of Profit Before Tax (PBT)
MOJO Watch
The company's income from non business activities is high; which is not a sustainable business model
Non Operating Income to PBT
